Alumni raised $1.45B in 2022 - Download Free Report Now

Glaukos (NASDAQ: GKOS)

Technology that restores natural physiologic outflow as a foundation of significant/steady/sustained glaucoma management.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Glaukos (NASDAQ: GKOS) plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About Glaukos (NASDAQ: GKOS)

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

Competing Startups


Companies We Work With